23andMe CEO Anne Wojcicki’s vision for changing healthcare as a ‘full-fledged biotech’

In the 17 years since its launch, 23 andMe has cemented its foothold in the at-home genetic testing market. It's just that the rest of the industry hasn't fully caught on, according to Anne Wojcicki, the company's co-founder and CEO. She assures them that yes, 23 andMe does real novel drug research in real labs.